跳至主要内容
临床试验/IRCT20211206053288N1
IRCT20211206053288N1尚未招募3 期

Evaluation the effects of atomoxetine on the improvement of cognitive impairment in Behcet’s disease patients

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 85 years(—)
性别
All

入选标准

  • Individuals diagnosed with Behcet's disease according to ICBD (International Criteria for Behcet's Disease) criteria
  • Presence of cognitive impairment detected by following tests: Forward digit span, Backward digit span, Trail making A, Trail making B, Verbal fluency

排除标准

  • History of cognitive impairment before affected by Behcet's disease
  • Substance use
  • History of adverse reactions to Atomoxetine

研究者

相似试验